Literature DB >> 2942205

Investigation of the relationship between sst1 and fdp mutations in yeast and their effect on trehalose synthesis.

R Charlab, D E Oliveira, A D Panek.   

Abstract

A specific deficiency in UDPG-linked trehalose-6-phosphate synthase in Saccharomyces has been associated with a single nuclear gene SST1 (M.S. Operti et al., Current Genetics, 5: 69-76, 1982). The sst1 phenotype was first observed in a pleiotropic fdp mutant which does not grow on mannose, sucrose, glucose or fructose, and in its partial spontaneous revertant (Q6R2) which acquired the capacity to grow on glucose but retained the mutant phenotype with respect to fructose. The sst1 mutants described in this paper are genetically derived from this partial revertant, a fact which suggested a link between sst1 and fdp mutations. All sst1 strains tested showed reduced growth on fructose in 24 h, which also characterizes the fdp mutation. Linkage studies revealed that the SST1 gene maps very close to the FDP gene. Furthermore, another mutant (cif) described as similar to fdp also lacked trehalose-6-phosphate synthase activity. Complementation tests between cif and fdp mutants indicated that the genes are allelic. These results suggest that SST1 and FDP are allelic and that the sst1 mutation might not be associated with the structural gene for trehalose-6-phosphate synthase but corresponds to one of the effects of the pleiotropic fdp mutation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2942205

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

1.  Glucose-induced regulatory defects in the Saccharomyces cerevisiae byp1 growth initiation mutant and identification of MIG1 as a partial suppressor.

Authors:  S Hohmann; K Huse; E Valentin; K Mbonyi; J M Thevelein; F K Zimmermann
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

Review 2.  Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.

Authors:  Arsa Thammahong; Srisombat Puttikamonkul; John R Perfect; Richard G Brennan; Robert A Cramer
Journal:  Microbiol Mol Biol Rev       Date:  2017-03-15       Impact factor: 11.056

3.  Identification of an ADPG-dependent trehalose synthase in Saccharomyces.

Authors:  V M Paschoalin; J T Silva; A D Panek
Journal:  Curr Genet       Date:  1989-08       Impact factor: 3.886

4.  Identification of extragenic suppressors of the cif1 mutation in Saccharomyces cerevisiae.

Authors:  M A Blázquez; C Gancedo
Journal:  Curr Genet       Date:  1994-02       Impact factor: 3.886

5.  Further evidence for the alternative pathway of trehalose synthesis linked to maltose utilization in Saccharomyces.

Authors:  V M Paschoalin; V L Costa-Carvalho; A D Panek
Journal:  Curr Genet       Date:  1986       Impact factor: 3.886

Review 6.  The RAS-adenylate cyclase pathway and cell cycle control in Saccharomyces cerevisiae.

Authors:  J M Thevelein
Journal:  Antonie Van Leeuwenhoek       Date:  1992-08       Impact factor: 2.271

7.  Control of glucose influx into glycolysis and pleiotropic effects studied in different isogenic sets of Saccharomyces cerevisiae mutants in trehalose biosynthesis.

Authors:  M J Neves; S Hohmann; W Bell; F Dumortier; K Luyten; J Ramos; P Cobbaert; W de Koning; Z Kaneva; J M Thevelein
Journal:  Curr Genet       Date:  1995-01       Impact factor: 3.886

8.  A yeast homologue of the bovine lens fibre MIP gene family complements the growth defect of a Saccharomyces cerevisiae mutant on fermentable sugars but not its defect in glucose-induced RAS-mediated cAMP signalling.

Authors:  L Van Aelst; S Hohmann; F K Zimmermann; A W Jans; J M Thevelein
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

9.  Fps1, a yeast member of the MIP family of channel proteins, is a facilitator for glycerol uptake and efflux and is inactive under osmotic stress.

Authors:  K Luyten; J Albertyn; W F Skibbe; B A Prior; J Ramos; J M Thevelein; S Hohmann
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.